# Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy

> **NCT02584842** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 400 (actual)

## Conditions studied

- Varicose Veins
- Venous Thrombosis
- Thromboembolism
- Bleeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02584842
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2015-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584842, "Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02584842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*